Alto Neuroscience (ANRO) Other Working Capital Changes (2023 - 2026)
Alto Neuroscience has reported Other Working Capital Changes over the past 4 years, most recently at $4.1 million for Q1 2026.
- Quarterly results put Other Working Capital Changes at $4.1 million for Q1 2026, up 144.09% from a year ago — trailing twelve months through Mar 2026 was $2.3 million (up 524.87% YoY), and the annual figure for FY2025 was -$101000.0, down 121.81%.
- Other Working Capital Changes reached $4.1 million in Q1 2026 per ANRO's latest filing, up from -$656000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $4.1 million in Q1 2026 and bottomed at -$744000.0 in Q3 2024.
- Median Other Working Capital Changes over the past 4 years was -$387000.0 (2023), compared with a mean of $323153.8.
- Peak annual rise in Other Working Capital Changes hit 283.84% in 2024, while the deepest fall reached 1007.32% in 2024.
- Over 4 years, Other Working Capital Changes stood at -$450000.0 in 2023, then changed by 0.0% to -$450000.0 in 2024, then tumbled by 45.78% to -$656000.0 in 2025, then surged by 729.57% to $4.1 million in 2026.
- Business Quant data shows Other Working Capital Changes for ANRO at $4.1 million in Q1 2026, -$656000.0 in Q4 2025, and -$628000.0 in Q3 2025.